Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 3 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Related structures:
AlphaFold database: A4H981
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003723 | RNA binding | 4 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 102 | 104 | PF00675 | 0.393 |
CLV_NRD_NRD_1 | 256 | 258 | PF00675 | 0.620 |
CLV_NRD_NRD_1 | 81 | 83 | PF00675 | 0.297 |
CLV_PCSK_KEX2_1 | 101 | 103 | PF00082 | 0.324 |
CLV_PCSK_KEX2_1 | 247 | 249 | PF00082 | 0.664 |
CLV_PCSK_PC1ET2_1 | 101 | 103 | PF00082 | 0.309 |
CLV_PCSK_PC1ET2_1 | 247 | 249 | PF00082 | 0.532 |
CLV_PCSK_SKI1_1 | 201 | 205 | PF00082 | 0.346 |
DOC_MAPK_gen_1 | 128 | 136 | PF00069 | 0.373 |
DOC_PP2B_PxIxI_1 | 1 | 7 | PF00149 | 0.340 |
DOC_USP7_MATH_1 | 228 | 232 | PF00917 | 0.488 |
DOC_USP7_MATH_1 | 256 | 260 | PF00917 | 0.709 |
DOC_USP7_UBL2_3 | 113 | 117 | PF12436 | 0.431 |
DOC_USP7_UBL2_3 | 119 | 123 | PF12436 | 0.192 |
DOC_USP7_UBL2_3 | 243 | 247 | PF12436 | 0.767 |
DOC_USP7_UBL2_3 | 258 | 262 | PF12436 | 0.497 |
LIG_14-3-3_CanoR_1 | 7 | 13 | PF00244 | 0.398 |
LIG_Actin_WH2_2 | 9 | 27 | PF00022 | 0.339 |
LIG_APCC_ABBAyCdc20_2 | 92 | 98 | PF00400 | 0.331 |
LIG_BRCT_BRCA1_1 | 92 | 96 | PF00533 | 0.331 |
LIG_FHA_1 | 220 | 226 | PF00498 | 0.377 |
LIG_FHA_2 | 177 | 183 | PF00498 | 0.302 |
LIG_FHA_2 | 21 | 27 | PF00498 | 0.439 |
LIG_FHA_2 | 244 | 250 | PF00498 | 0.524 |
LIG_FHA_2 | 45 | 51 | PF00498 | 0.540 |
LIG_LIR_Apic_2 | 72 | 76 | PF02991 | 0.486 |
LIG_LIR_Gen_1 | 181 | 189 | PF02991 | 0.354 |
LIG_LIR_Nem_3 | 181 | 186 | PF02991 | 0.354 |
LIG_MAD2 | 63 | 71 | PF02301 | 0.530 |
LIG_SH2_CRK | 215 | 219 | PF00017 | 0.209 |
LIG_SH2_NCK_1 | 215 | 219 | PF00017 | 0.290 |
LIG_SH2_STAT5 | 207 | 210 | PF00017 | 0.351 |
LIG_SH2_STAT5 | 213 | 216 | PF00017 | 0.358 |
LIG_SH3_3 | 222 | 228 | PF00018 | 0.524 |
LIG_TRAF2_1 | 66 | 69 | PF00917 | 0.534 |
MOD_CK2_1 | 176 | 182 | PF00069 | 0.360 |
MOD_CK2_1 | 233 | 239 | PF00069 | 0.661 |
MOD_CK2_1 | 248 | 254 | PF00069 | 0.664 |
MOD_GlcNHglycan | 192 | 195 | PF01048 | 0.302 |
MOD_GSK3_1 | 256 | 263 | PF00069 | 0.677 |
MOD_NEK2_2 | 20 | 25 | PF00069 | 0.476 |
MOD_PKA_2 | 256 | 262 | PF00069 | 0.481 |
MOD_PKA_2 | 44 | 50 | PF00069 | 0.507 |
MOD_PKA_2 | 6 | 12 | PF00069 | 0.343 |
MOD_Plk_4 | 219 | 225 | PF00069 | 0.324 |
MOD_SUMO_for_1 | 33 | 36 | PF00179 | 0.434 |
MOD_SUMO_rev_2 | 49 | 55 | PF00179 | 0.434 |
MOD_SUMO_rev_2 | 58 | 64 | PF00179 | 0.392 |
TRG_DiLeu_BaEn_3 | 159 | 165 | PF01217 | 0.331 |
TRG_ENDOCYTIC_2 | 215 | 218 | PF00928 | 0.317 |
TRG_ER_diArg_1 | 79 | 82 | PF00400 | 0.346 |
TRG_NLS_Bipartite_1 | 247 | 261 | PF00514 | 0.646 |
TRG_NLS_MonoExtN_4 | 255 | 261 | PF00514 | 0.606 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P4U4 | Leptomonas seymouri | 70% | 100% |
A0A0S4JKD1 | Bodo saltans | 29% | 85% |
A0A1X0NK68 | Trypanosomatidae | 50% | 100% |
A0A3Q8IKE2 | Leishmania donovani | 71% | 96% |
A0A422NF86 | Trypanosoma rangeli | 55% | 100% |
A4HJR9 | Leishmania braziliensis | 99% | 100% |
A4I785 | Leishmania infantum | 71% | 96% |
C9ZMG4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 42% | 100% |
E9B280 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 69% | 96% |
Q4Q5X8 | Leishmania major | 69% | 100% |
V5BGM8 | Trypanosoma cruzi | 55% | 94% |